[{"id":47,"run_id":2,"as_of":"2026-08-08","ticker":"ABCL","company":"Abcellera Biologics Inc.","source":"weekly","conviction":65.1,"technical":65.1,"stage":"Late Extension","gated":true,"n_gates":1,"gates":["Overlapping range behaviour — efficiency ratio 0.11 vs the 0.15 threshold (borderline, watch for resolution)."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":6.93,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":15.5,"Volatility behaviour":13.0,"Cross-asset confirmation":13.0,"Sponsorship / positioning":10.6,"Catalyst alignment (insider)":13.0},"total_cfo_value":145692.0,"total_other_value":806404.0,"n_cfo_buys":1.0,"n_other_buys":3.0,"has_cfo_buy":true,"roles_buying":"1 CFO, 1 Director, 2 Unclassified","npr":1.0,"cluster_insiders":3.0,"days_since_buy":162.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-08T19:39:50.085595+00:00"},{"id":113,"run_id":6,"as_of":"2026-08-10","ticker":"ABCL","company":"Abcellera Biologics Inc.","source":"weekly","conviction":62.7,"technical":62.2,"stage":"Late Extension","gated":false,"n_gates":0,"gates":[],"sizing_low":10000.0,"sizing_high":14000.0,"sizing_label":"Probe","close":9.3,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":17.1,"Volatility behaviour":9.0,"Cross-asset confirmation":13.0,"Sponsorship / positioning":10.7,"Catalyst alignment (insider)":12.9},"total_cfo_value":145692.0,"total_other_value":806404.0,"n_cfo_buys":1.0,"n_other_buys":3.0,"has_cfo_buy":true,"roles_buying":"1 CFO, 1 Director, 2 Unclassified","npr":1.0,"cluster_insiders":3.0,"days_since_buy":164.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-10T16:32:51.801846+00:00"},{"id":700,"run_id":17,"as_of":"2026-08-11","ticker":"ABCL","company":"Abcellera Biologics Inc.","source":"weekly","conviction":65.1,"technical":65.3,"stage":"Late Extension","gated":false,"n_gates":0,"gates":[],"sizing_low":10000.0,"sizing_high":14000.0,"sizing_label":"Probe","close":10.08,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":18.2,"Volatility behaviour":9.0,"Cross-asset confirmation":13.6,"Sponsorship / positioning":11.4,"Catalyst alignment (insider)":12.9},"total_cfo_value":145692.0,"total_other_value":806404.0,"n_cfo_buys":1.0,"n_other_buys":3.0,"has_cfo_buy":true,"roles_buying":"1 CFO, 1 Director, 2 Unclassified","npr":1.0,"cluster_insiders":3.0,"days_since_buy":165.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-11T15:02:55.030268+00:00"},{"id":1284,"run_id":27,"as_of":"2026-08-12","ticker":"ABCL","company":"Abcellera Biologics Inc.","source":"weekly","conviction":65.5,"technical":65.8,"stage":"Late Extension","gated":false,"n_gates":0,"gates":[],"sizing_low":10000.0,"sizing_high":14000.0,"sizing_label":"Probe","close":9.98,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":18.1,"Volatility behaviour":9.0,"Cross-asset confirmation":14.1,"Sponsorship / positioning":11.4,"Catalyst alignment (insider)":12.9},"total_cfo_value":145692.0,"total_other_value":806404.0,"n_cfo_buys":1.0,"n_other_buys":3.0,"has_cfo_buy":true,"roles_buying":"1 CFO, 1 Director, 2 Unclassified","npr":1.0,"cluster_insiders":3.0,"days_since_buy":166.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-12T16:17:35.947482+00:00"},{"id":1347,"run_id":31,"as_of":"2026-08-13","ticker":"ABCL","company":"Abcellera Biologics Inc.","source":"weekly","conviction":66.8,"technical":67.4,"stage":"Late Extension","gated":false,"n_gates":0,"gates":[],"sizing_low":10000.0,"sizing_high":14000.0,"sizing_label":"Probe","close":10.64,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":9.0,"Cross-asset confirmation":13.5,"Sponsorship / positioning":12.9,"Catalyst alignment (insider)":12.9},"total_cfo_value":145692.0,"total_other_value":806404.0,"n_cfo_buys":1.0,"n_other_buys":3.0,"has_cfo_buy":true,"roles_buying":"1 CFO, 1 Director, 2 Unclassified","npr":1.0,"cluster_insiders":3.0,"days_since_buy":167.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-13T00:11:32.116666+00:00"},{"id":1994,"run_id":41,"as_of":"2026-08-14","ticker":"ABCL","company":"Abcellera Biologics Inc.","source":"weekly","conviction":71.4,"technical":67.8,"stage":"Late Extension","gated":false,"n_gates":0,"gates":[],"sizing_low":10000.0,"sizing_high":14000.0,"sizing_label":"Probe","close":11.38,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":9.0,"Cross-asset confirmation":13.0,"Sponsorship / positioning":13.7,"Catalyst alignment (insider)":17.2},"total_cfo_value":529596.0,"total_other_value":1287437.0,"n_cfo_buys":2.0,"n_other_buys":4.0,"has_cfo_buy":true,"roles_buying":"2 CFO, 2 Director, 2 Unclassified","npr":1.0,"cluster_insiders":4.0,"days_since_buy":0.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-14T01:48:05.981934+00:00"},{"id":3193,"run_id":53,"as_of":"2026-08-17","ticker":"ABCL","company":"Abcellera Biologics Inc.","source":"weekly","conviction":71.7,"technical":68.1,"stage":"Late Extension","gated":false,"n_gates":0,"gates":[],"sizing_low":10000.0,"sizing_high":14000.0,"sizing_label":"Probe","close":11.18,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":9.0,"Cross-asset confirmation":13.0,"Sponsorship / positioning":14.0,"Catalyst alignment (insider)":17.2},"total_cfo_value":529596.0,"total_other_value":1287437.0,"n_cfo_buys":2.0,"n_other_buys":4.0,"has_cfo_buy":true,"roles_buying":"2 CFO, 2 Director, 2 Unclassified","npr":1.0,"cluster_insiders":4.0,"days_since_buy":3.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-17T16:20:45.815019+00:00"},{"id":3778,"run_id":64,"as_of":"2026-08-18","ticker":"ABCL","company":"Abcellera Biologics Inc.","source":"weekly","conviction":64.2,"technical":68.6,"stage":"Late Extension","gated":false,"n_gates":0,"gates":[],"sizing_low":10000.0,"sizing_high":14000.0,"sizing_label":"Probe","close":11.16,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":9.0,"Cross-asset confirmation":13.4,"Sponsorship / positioning":14.0,"Catalyst alignment (insider)":9.3},"total_cfo_value":529596.0,"total_other_value":1397737.0,"n_cfo_buys":2.0,"n_other_buys":5.0,"has_cfo_buy":true,"roles_buying":"2 CFO, 3 Director, 2 Unclassified","npr":1.0,"cluster_insiders":4.0,"days_since_buy":4.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-18T18:49:14.813074+00:00"},{"id":4447,"run_id":80,"as_of":"2026-08-19","ticker":"ABCL","company":"Abcellera Biologics Inc.","source":"weekly","conviction":66.0,"technical":70.9,"stage":"Late Extension","gated":false,"n_gates":0,"gates":[],"sizing_low":10000.0,"sizing_high":14000.0,"sizing_label":"Probe","close":12.01,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":18.5,"Volatility behaviour":9.0,"Cross-asset confirmation":15.2,"Sponsorship / positioning":14.0,"Catalyst alignment (insider)":9.3},"total_cfo_value":529596.0,"total_other_value":1397737.0,"n_cfo_buys":2.0,"n_other_buys":5.0,"has_cfo_buy":true,"roles_buying":"2 CFO, 3 Director, 2 Unclassified","npr":1.0,"cluster_insiders":4.0,"days_since_buy":5.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-19T23:06:33.541677+00:00"},{"id":4573,"run_id":113,"as_of":"2026-08-20","ticker":"ABCL","company":"Abcellera Biologics Inc.","source":"weekly","conviction":65.4,"technical":70.1,"stage":"Late Extension","gated":false,"n_gates":0,"gates":[],"sizing_low":10000.0,"sizing_high":14000.0,"sizing_label":"Probe","close":11.57,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":18.4,"Volatility behaviour":9.0,"Cross-asset confirmation":14.7,"Sponsorship / positioning":14.0,"Catalyst alignment (insider)":9.3},"total_cfo_value":529596.0,"total_other_value":1397737.0,"n_cfo_buys":2.0,"n_other_buys":5.0,"has_cfo_buy":true,"roles_buying":"2 CFO, 3 Director, 2 Unclassified","npr":1.0,"cluster_insiders":4.0,"days_since_buy":6.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-20T21:53:10.611004+00:00"},{"id":5247,"run_id":173,"as_of":"2026-08-21","ticker":"ABCL","company":"Abcellera Biologics Inc.","source":"weekly","conviction":72.9,"technical":79.5,"stage":"Late Extension","gated":false,"n_gates":0,"gates":[],"sizing_low":10000.0,"sizing_high":14000.0,"sizing_label":"Probe","close":11.32,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":18.0,"Volatility behaviour":16.0,"Cross-asset confirmation":15.6,"Sponsorship / positioning":14.0,"Catalyst alignment (insider)":9.3},"total_cfo_value":529596.0,"total_other_value":1397737.0,"n_cfo_buys":2.0,"n_other_buys":5.0,"has_cfo_buy":true,"roles_buying":"2 CFO, 3 Director, 2 Unclassified","npr":1.0,"cluster_insiders":4.0,"days_since_buy":7.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-21T20:52:35.383879+00:00"},{"id":5399,"run_id":242,"as_of":"2026-08-22","ticker":"ABCL","company":"Abcellera Biologics Inc.","source":"weekly","conviction":80.7,"technical":79.5,"stage":"Late Extension","gated":false,"n_gates":0,"gates":[],"sizing_low":16000.0,"sizing_high":20000.0,"sizing_label":"Standard","close":11.32,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":18.0,"Volatility behaviour":16.0,"Cross-asset confirmation":15.6,"Sponsorship / positioning":14.0,"Catalyst alignment (insider)":17.1},"total_cfo_value":529596.0,"total_other_value":1397737.0,"n_cfo_buys":2.0,"n_other_buys":5.0,"has_cfo_buy":true,"roles_buying":"2 CFO, 3 Director, 2 Unclassified","npr":1.0,"cluster_insiders":4.0,"days_since_buy":8.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-22T14:49:55.536534+00:00"},{"id":5494,"run_id":263,"as_of":"2026-08-24","ticker":"ABCL","company":"AbCellera Biologics Inc.","source":"ticker","conviction":79.0,"technical":77.1,"stage":"Late Extension","gated":false,"n_gates":0,"gates":[],"sizing_low":16000.0,"sizing_high":20000.0,"sizing_label":"Standard","close":10.61,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":17.0,"Volatility behaviour":16.0,"Cross-asset confirmation":14.7,"Sponsorship / positioning":14.0,"Catalyst alignment (insider)":17.3},"total_cfo_value":529596.0,"total_other_value":1968179.0,"n_cfo_buys":2.0,"n_other_buys":6.0,"has_cfo_buy":true,"roles_buying":"2 CFO, 4 Director, 2 Unclassified","npr":1.0,"cluster_insiders":4.0,"days_since_buy":10.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-24T13:43:37.609921+00:00"},{"id":6196,"run_id":270,"as_of":"2026-08-25","ticker":"ABCL","company":"Abcellera Biologics Inc.","source":"weekly","conviction":80.4,"technical":79.1,"stage":"Late Extension","gated":false,"n_gates":0,"gates":[],"sizing_low":16000.0,"sizing_high":20000.0,"sizing_label":"Standard","close":12.5,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":18.0,"Volatility behaviour":16.0,"Cross-asset confirmation":15.3,"Sponsorship / positioning":14.0,"Catalyst alignment (insider)":17.1},"total_cfo_value":529596.0,"total_other_value":1968179.0,"n_cfo_buys":2.0,"n_other_buys":6.0,"has_cfo_buy":true,"roles_buying":"2 CFO, 4 Director, 2 Unclassified","npr":1.0,"cluster_insiders":4.0,"days_since_buy":11.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-25T16:51:35.628977+00:00"},{"id":6889,"run_id":309,"as_of":"2026-08-26","ticker":"ABCL","company":"Abcellera Biologics Inc.","source":"weekly","conviction":79.4,"technical":78.4,"stage":"Late Extension","gated":false,"n_gates":0,"gates":[],"sizing_low":16000.0,"sizing_high":20000.0,"sizing_label":"Standard","close":12.24,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":17.5,"Volatility behaviour":16.0,"Cross-asset confirmation":15.2,"Sponsorship / positioning":14.0,"Catalyst alignment (insider)":16.7},"total_cfo_value":383904.0,"total_other_value":1387895.0,"n_cfo_buys":1.0,"n_other_buys":5.0,"has_cfo_buy":true,"roles_buying":"1 CFO, 4 Director, 1 Unclassified","npr":1.0,"cluster_insiders":4.0,"days_since_buy":12.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-26T00:32:08.701082+00:00"},{"id":7692,"run_id":390,"as_of":"2026-08-27","ticker":"ABCL","company":"Abcellera Biologics Inc.","source":"weekly","conviction":78.9,"technical":77.8,"stage":"Late Extension","gated":false,"n_gates":0,"gates":[],"sizing_low":16000.0,"sizing_high":20000.0,"sizing_label":"Standard","close":12.4,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":18.0,"Volatility behaviour":16.0,"Cross-asset confirmation":14.2,"Sponsorship / positioning":14.0,"Catalyst alignment (insider)":16.7},"total_cfo_value":383904.0,"total_other_value":1387895.0,"n_cfo_buys":1.0,"n_other_buys":5.0,"has_cfo_buy":true,"roles_buying":"1 CFO, 4 Director, 1 Unclassified","npr":1.0,"cluster_insiders":4.0,"days_since_buy":13.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-27T20:17:55.852107+00:00"},{"id":8320,"run_id":411,"as_of":"2026-08-28","ticker":"ABCL","company":"Abcellera Biologics Inc.","source":"weekly","conviction":77.3,"technical":77.6,"stage":"Late Extension","gated":false,"n_gates":0,"gates":[],"sizing_low":16000.0,"sizing_high":20000.0,"sizing_label":"Standard","close":12.4,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":18.0,"Volatility behaviour":16.0,"Cross-asset confirmation":14.1,"Sponsorship / positioning":14.0,"Catalyst alignment (insider)":15.2},"total_cfo_value":383904.0,"total_other_value":1257175.0,"n_cfo_buys":1.0,"n_other_buys":4.0,"has_cfo_buy":true,"roles_buying":"1 CFO, 4 Director","npr":1.0,"cluster_insiders":3.0,"days_since_buy":15.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-29T11:54:20.316176+00:00"},{"id":8925,"run_id":413,"as_of":"2026-08-30","ticker":"ABCL","company":"Abcellera Biologics Inc.","source":"weekly","conviction":75.5,"technical":75.4,"stage":"Late Extension","gated":false,"n_gates":0,"gates":[],"sizing_low":16000.0,"sizing_high":20000.0,"sizing_label":"Standard","close":11.35,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":17.3,"Volatility behaviour":16.0,"Cross-asset confirmation":13.0,"Sponsorship / positioning":14.0,"Catalyst alignment (insider)":15.2},"total_cfo_value":383904.0,"total_other_value":1257175.0,"n_cfo_buys":1.0,"n_other_buys":4.0,"has_cfo_buy":true,"roles_buying":"1 CFO, 4 Director","npr":1.0,"cluster_insiders":3.0,"days_since_buy":16.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-30T01:15:14.903614+00:00"},{"id":9013,"run_id":414,"as_of":"2026-08-31","ticker":"ABCL","company":"Abcellera Biologics Inc.","source":"weekly","conviction":77.1,"technical":77.4,"stage":"Late Extension","gated":false,"n_gates":0,"gates":[],"sizing_low":16000.0,"sizing_high":20000.0,"sizing_label":"Standard","close":11.48,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":18.4,"Volatility behaviour":16.0,"Cross-asset confirmation":13.5,"Sponsorship / positioning":14.0,"Catalyst alignment (insider)":15.2},"total_cfo_value":383904.0,"total_other_value":1257175.0,"n_cfo_buys":1.0,"n_other_buys":4.0,"has_cfo_buy":true,"roles_buying":"1 CFO, 4 Director","npr":1.0,"cluster_insiders":3.0,"days_since_buy":17.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-31T21:22:03.535773+00:00"},{"id":9608,"run_id":417,"as_of":"2026-09-01","ticker":"ABCL","company":"Abcellera Biologics Inc.","source":"weekly","conviction":78.6,"technical":79.2,"stage":"Late Extension","gated":false,"n_gates":0,"gates":[],"sizing_low":16000.0,"sizing_high":20000.0,"sizing_label":"Standard","close":11.28,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":19.0,"Volatility behaviour":16.0,"Cross-asset confirmation":14.4,"Sponsorship / positioning":14.0,"Catalyst alignment (insider)":15.2},"total_cfo_value":383904.0,"total_other_value":1257175.0,"n_cfo_buys":1.0,"n_other_buys":4.0,"has_cfo_buy":true,"roles_buying":"1 CFO, 4 Director","npr":1.0,"cluster_insiders":3.0,"days_since_buy":18.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-09-01T21:37:53.063049+00:00"},{"id":9700,"run_id":418,"as_of":"2026-09-02","ticker":"ABCL","company":"Abcellera Biologics Inc.","source":"weekly","conviction":79.3,"technical":80.1,"stage":"Late Extension","gated":false,"n_gates":0,"gates":[],"sizing_low":16000.0,"sizing_high":20000.0,"sizing_label":"Standard","close":11.36,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":19.3,"Volatility behaviour":16.0,"Cross-asset confirmation":14.8,"Sponsorship / positioning":14.0,"Catalyst alignment (insider)":15.2},"total_cfo_value":383904.0,"total_other_value":1257175.0,"n_cfo_buys":1.0,"n_other_buys":4.0,"has_cfo_buy":true,"roles_buying":"1 CFO, 4 Director","npr":1.0,"cluster_insiders":3.0,"days_since_buy":19.0,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-09-02T21:23:53.374859+00:00"}]